Scynexis

SCYX • NASDAQ •
Overview Stats Financials News

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range $1.35-$3.87
Market Cap $88.7M
Shares Short 1M

Financials

See more
Revenue (12 Mos) $140.3M
Revenue Growth (YoY) 21.5%
Gross Profit (12 Mos) $12.8M
Diluted EPS $2.11

News

See more

Yahoo Finance • 6 months ago

DEADLINE ALERT for HLLY, SCYX, LICY, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Yahoo Finance • 6 months ago

SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm

Yahoo Finance • 6 months ago

DEADLINE ALERT for OTLK, HLLY, SCYX, LICY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Yahoo Finance • 6 months ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SCYNEXIS, Inc. (SCYX) Investors

About

CEO Mr. David Gonzalez Angulo M.D.
Address 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full-Time Employees 29